Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin’s lymphoma

Author： Kilickap Saadettin   Yavuz Bunyamin   Aksoy Sercan   Sahiner Levent   Dincer Murat   Harputluoglu Hakan   Erman Mustafa   Aytemir Kudret   Tokgozoglu Lale   Barista Ibrahim  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.25, Iss.4, 2008-12, pp. : 437-442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20(+) non-Hodgkin’s lymphoma

By Dzietczenia Justyna   Wróbel Tomasz   Mazur Grzegorz   Poręba Rafał   Jaźwiec Bożena   Kuliczkowski Kazimierz  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 743-746

Humana Press, Inc

Access to resources Recommend Favorite

Clinical randomized comparative trial of DICE regimen and CHOP regimen in treating intermediate and high grade non-Hodgkin's lymphoma

By Wang Wenwu  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 107-110

Springer Publishing Company

Access to resources Recommend Favorite

CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab

By DiJoseph John   Dougher Maureen   Armellino Douglas   Kalyandrug Lyka   Kunz Arthur   Boghaert Erwin   Hamann Philip   Damle Nitin  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1107-1117

Springer Publishing Company

Access to resources Recommend Favorite

Lack of neuroprotection by an ACTH (4–9) analogue. A randomized trial in patients treated with vincristine for Hodgkin’s or non-Hodgkin’s lymphoma

By Koeppen S.   Verstappen C.   Körte R.   Scheulen M.   Strumberg D.   Postma T.   Heimans J.   Huijgens P.   Kiburg B.   Renzing-Köhler K.   Diener H.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 3, 2004-03 ,pp. : 153-160

Springer Publishing Company

Access to resources Recommend Favorite

Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin’s lymphoma: A comparison of doxorubicin and pirarubicin: a randomized phase II study

By Tsurumi Hisashi   Yamada Toshiki   Sawada Michio   Kasahara Senji   Kanemura Nobuhiro   Kojima Yasushi   Fukuno Kenji   Hara Takeshi   Saio Masanao   Takahashi Takeshi   Oyama Masami   Ozawa Keiya   Takami Tsuyoshi   Moriwaki Hisataka  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 2, 2004-02 ,pp. : 107-113

Springer Publishing Company

Access to resources Recommend Favorite